Identification and Characterization of Tumor-Initiating Cells in Multiple Myeloma
Minjie Gao(Jiangnan University), Fenghuang Zhan(Winthrop Rockefeller Foundation), Gregory S. Thomas(Orange Coast Memorial Medical Center), Guido Tricot, Siegfried Janz(National Research Council Canada), Huojun Cao, Yogesh Jethava(University of Iowa), Ye Yang(Yangtze University), Mohamed E. Salama(The University of Texas at San Antonio Health Science Center), Ivana Frech(University of Iowa), Jumei Shi(Tongji University), Hua Bai(Nanjing University of Chinese Medicine), Gail A. Bishop(University of Iowa), Kalyan Nadiminti(University of Iowa Hospitals and Clinics), Yujie Wu(Nanjing Medical University), Peter Altevogt(German Cancer Research Center), Reinaldo Franqui-Machin(University of Iowa), Jiliang Xia(Central South University), Lijuan Chen(Jiangsu Province Hospital), Michael H. Tomasson(University of Iowa), Yuqi Zhu(Fudan University)
Cited by 47
Related Papers
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Frequent Engagement of the Classical and Alternative NF-κB Pathways by Diverse Genetic Abnormalities in Multiple Myeloma
|Cancer Cell|2007|949
<i>TP53</i> and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
|New England Journal of Medicine|2016|783
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
|Cancer Cell|2017|619
Alternative splicing and cancer: a systematic review
|Signal Transduction and Targeted Therapy|2021|489